BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37382156)

  • 21. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
    Tajima S; Koda K
    Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
    Xu H; Genega EM; Zhuang L; Zhou M
    Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome.
    Bahmad HF; Lopez O; Moreno JCA; Lopez K; Malik F; Salami A; Nieder AM; Omarzai Y; Poppiti RJ
    Ann Diagn Pathol; 2022 Dec; 61():152030. PubMed ID: 36055007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients.
    Wolf H; Olsen PR; Fischer A; Højgaard K
    Scand J Urol Nephrol; 1987; 21(1):33-8. PubMed ID: 3589521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
    Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
    Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
    McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.
    Amin MB; Trpkov K; Lopez-Beltran A; Grignon D;
    Am J Surg Pathol; 2014 Aug; 38(8):e20-34. PubMed ID: 25029121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.
    Fujii N; Hoshii Y; Hirata H; Mori J; Shimizu K; Kobayashi K; Kawai Y; Inoue R; Yamamoto Y; Matsumoto H; Nagao K; Matsuyama H
    Jpn J Clin Oncol; 2017 Jun; 47(6):560-567. PubMed ID: 28334788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
    Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
    Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head-to-head: how many categories for grading urothelial carcinoma?
    Varma M; Compérat E; van der Kwast T
    Histopathology; 2024 Feb; 84(3):421-428. PubMed ID: 37936516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
    Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
    J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.